0001209191-21-068955.txt : 20211210
0001209191-21-068955.hdr.sgml : 20211210
20211210131346
ACCESSION NUMBER: 0001209191-21-068955
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211207
FILED AS OF DATE: 20211210
DATE AS OF CHANGE: 20211210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hayden Michael R
CENTRAL INDEX KEY: 0001352908
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39781
FILM NUMBER: 211484585
MAIL ADDRESS:
STREET 1: C/O ASPREVA PHARMACEUTICALS CORPORATION
STREET 2: 1203-4464 MARKHAM STREET
CITY: VICTORIA
STATE: A1
ZIP: V8Z 7X8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AbCellera Biologics Inc.
CENTRAL INDEX KEY: 0001703057
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2215 YUKON STREET
CITY: VANCOUVER
STATE: A1
ZIP: V5Y 0A1
BUSINESS PHONE: (604) 559-9005
MAIL ADDRESS:
STREET 1: 2215 YUKON STREET
CITY: VANCOUVER
STATE: A1
ZIP: V5Y 0A1
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-12-07
0
0001703057
AbCellera Biologics Inc.
ABCL
0001352908
Hayden Michael R
C/O ABCELLERA BIOLOGICS INC.
2215 YUKON STREET
VANCOUVER
A1
BRITISH COLUMBIA, CANADA
1
0
0
0
Common Shares
1273397
I
See footnote
Common Shares
118245
I
By spouse
Share option (right to buy)
17.58
2021-08-27
4
A
0
34282
0.00
A
2022-08-27
2031-08-27
Common Shares
34282
674282
D
Share option (right to buy)
14.55
2021-12-07
4
A
0
45532
0.00
A
2022-12-07
2031-12-07
Common Shares
45532
449814
D
These shares are held by Genworks 2 Consulting, Inc. ("Genworks 2"). The Reporting Person's spouse has sole voting and investment power with respect to the shares held by Genworks 2. The reporting person disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest, if any, therein.
/s/ Tryn Stimart, attorney in fact
2021-12-10